FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003308257> ?p ?o ?g. }

• W2003308257 endingPage "1135" @default.
• W2003308257 startingPage "1131" @default.
• W2003308257 abstract "Intravenous cyclosporine is active in 60% to 80% of patients with ulcerative colitis (UC) who failed to respond to intravenous corticosteroids. Several studies have suggested that cyclosporine in microemulsion form (Neoral) has some efficacy in this setting, but the optimal dose, blood level, time to response, and remission need to be better defined. The aim of this study was to evaluate the response to Neoral and its toxicity in active corticosteroid-refractory UC.Between March 2002 and August 2005, 20 courses of Neoral [initial dose, 2.3 mg/kg (range, 1.8 to 2.8 mg/kg) every 12 hours] were prescribed in 19 consecutive patients for a UC attack that did not respond to intravenous methylprednisolone. All patients received prophylaxis against Pneumocystis carinii.Response was obtained in 17 of 20 attacks (85%) after 3.5 days (range, 1 to 7). Remission was obtained in 15 of 20 attacks (75%) after 13 days (range, 2 to 30 days). Four responders relapsed and underwent colectomy 21 to 900 days after the start of Neoral. Overall, 14 of 19 patients (74%) were colectomy free after a median follow-up of 8 months (range, 1 to 41 months). Cyclosporine blood levels were measured at fasting (C0) and 2 hours after Neoral administration (C2) in a subgroup of 10 responders. The results were 103 ng/mL (range, 32 to 240 ng/mL) for C0 and 761 ng/mL (183 to 1390 ng/mL) for C2. One severe bedridden patient with neonatal encephalopathy died. Main side effects observed were mild transient renal impairment (n = 2), hypertension (n = 1), cytomegalovirus infection (n = 2), and esophageal candidiasis (n = 1).In active corticosteroid-refractory UC, Neoral seems to have the same efficacy and toxicity as the intravenous form. Trough target cyclosporine blood levels should not exceed 100 ng/mL for C0 and 700 ng/mL for C2." @default.
• W2003308257 created "2016-06-24" @default.
• W2003308257 creator A5016587325 @default.
• W2003308257 creator A5024460514 @default.
• W2003308257 creator A5026208646 @default.
• W2003308257 creator A5070426915 @default.
• W2003308257 creator A5072822479 @default.
• W2003308257 creator A5075026686 @default.
• W2003308257 creator A5083950096 @default.
• W2003308257 date "2006-12-01" @default.
• W2003308257 modified "2023-10-10" @default.
• W2003308257 title "Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (neoral)" @default.
• W2003308257 cites W1748466511 @default.
• W2003308257 cites W1964593079 @default.
• W2003308257 cites W1971404276 @default.
• W2003308257 cites W1974242080 @default.
• W2003308257 cites W1984341857 @default.
• W2003308257 cites W1987925515 @default.
• W2003308257 cites W1989112294 @default.
• W2003308257 cites W1992650609 @default.
• W2003308257 cites W1992886649 @default.
• W2003308257 cites W2016247805 @default.
• W2003308257 cites W2019545195 @default.
• W2003308257 cites W2021544053 @default.
• W2003308257 cites W2061002171 @default.
• W2003308257 cites W2068255175 @default.
• W2003308257 cites W2102897127 @default.
• W2003308257 cites W2107019957 @default.
• W2003308257 cites W2112768046 @default.
• W2003308257 cites W2114669439 @default.
• W2003308257 cites W2118431104 @default.
• W2003308257 cites W2171297959 @default.
• W2003308257 cites W2320941231 @default.
• W2003308257 cites W2333740086 @default.
• W2003308257 cites W4241890595 @default.
• W2003308257 doi "https://doi.org/10.1097/01.mib.0000235096.78736.8e" @default.
• W2003308257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17119387" @default.
• W2003308257 hasPublicationYear "2006" @default.
• W2003308257 type Work @default.
• W2003308257 sameAs 2003308257 @default.
• W2003308257 citedByCount "31" @default.
• W2003308257 countsByYear W20033082572012 @default.
• W2003308257 countsByYear W20033082572013 @default.
• W2003308257 countsByYear W20033082572014 @default.
• W2003308257 countsByYear W20033082572015 @default.
• W2003308257 countsByYear W20033082572016 @default.
• W2003308257 countsByYear W20033082572018 @default.
• W2003308257 countsByYear W20033082572022 @default.
• W2003308257 countsByYear W20033082572023 @default.
• W2003308257 crossrefType "journal-article" @default.
• W2003308257 hasAuthorship W2003308257A5016587325 @default.
• W2003308257 hasAuthorship W2003308257A5024460514 @default.
• W2003308257 hasAuthorship W2003308257A5026208646 @default.
• W2003308257 hasAuthorship W2003308257A5070426915 @default.
• W2003308257 hasAuthorship W2003308257A5072822479 @default.
• W2003308257 hasAuthorship W2003308257A5075026686 @default.
• W2003308257 hasAuthorship W2003308257A5083950096 @default.
• W2003308257 hasBestOaLocation W20033082571 @default.
• W2003308257 hasConcept C121332964 @default.
• W2003308257 hasConcept C126322002 @default.
• W2003308257 hasConcept C141071460 @default.
• W2003308257 hasConcept C142424586 @default.
• W2003308257 hasConcept C2776667177 @default.
• W2003308257 hasConcept C2776804153 @default.
• W2003308257 hasConcept C2779134260 @default.
• W2003308257 hasConcept C2780372218 @default.
• W2003308257 hasConcept C2780479503 @default.
• W2003308257 hasConcept C42219234 @default.
• W2003308257 hasConcept C71924100 @default.
• W2003308257 hasConcept C87355193 @default.
• W2003308257 hasConcept C90924648 @default.
• W2003308257 hasConceptScore W2003308257C121332964 @default.
• W2003308257 hasConceptScore W2003308257C126322002 @default.
• W2003308257 hasConceptScore W2003308257C141071460 @default.
• W2003308257 hasConceptScore W2003308257C142424586 @default.
• W2003308257 hasConceptScore W2003308257C2776667177 @default.
• W2003308257 hasConceptScore W2003308257C2776804153 @default.
• W2003308257 hasConceptScore W2003308257C2779134260 @default.
• W2003308257 hasConceptScore W2003308257C2780372218 @default.
• W2003308257 hasConceptScore W2003308257C2780479503 @default.
• W2003308257 hasConceptScore W2003308257C42219234 @default.
• W2003308257 hasConceptScore W2003308257C71924100 @default.
• W2003308257 hasConceptScore W2003308257C87355193 @default.
• W2003308257 hasConceptScore W2003308257C90924648 @default.
• W2003308257 hasIssue "12" @default.
• W2003308257 hasLocation W20033082571 @default.
• W2003308257 hasLocation W20033082572 @default.
• W2003308257 hasLocation W20033082573 @default.
• W2003308257 hasLocation W20033082574 @default.
• W2003308257 hasOpenAccess W2003308257 @default.
• W2003308257 hasPrimaryLocation W20033082571 @default.
• W2003308257 hasRelatedWork W1541393747 @default.
• W2003308257 hasRelatedWork W178943794 @default.
• W2003308257 hasRelatedWork W1978906444 @default.
• W2003308257 hasRelatedWork W2045823426 @default.
• W2003308257 hasRelatedWork W2124185266 @default.
• W2003308257 hasRelatedWork W2312951914 @default.
• W2003308257 hasRelatedWork W2324289808 @default.

• next